2026 Future Healthcare & Pharma Top 100 Summit Unveils Full Agenda and Initial Lineup of Keynote Speakers
Over the past year, upfront payments for overseas licensing of domestically developed innovative drugs have seen breakthrough growth, while numerous “world-first” achievements have emerged among the three categories of innovative medical devices. The financing structure has undergone profound changes, with IPO thresholds shifting from a focus on scale to a priority on value. The market no longer pays for mere concepts; instead, it demands proof of clinical value, clear commercialization pathways, and global competitiveness.
This is precisely the starting point for the comprehensive upgrade chosen by the 2026 Future Healthcare & Pharmaceuticals Top 100 Conference.
May 19–21, hosted by VCBeat2026 Future Healthcare & Pharmaceuticals Top 100 Conferencewill be“Showcase, Trading, and Empowerment of Innovative Assets in China’s Healthcare Sector”Grandly held at the Platinum Hanjue Hotel in Minhang District, Shanghai.
Scan the QR code to register
This conference is themed“Forum + Selection + Matchmaking”Centered around this core, it features sections such as the Main Forum, Hot-Track Forums, Innovative Asset Exhibition Area, and 1-on-1 Negotiation Zone, building a full-chain, high-efficiency matchmaking ecosystem. GatheringTop academicians, clinical experts, corporate leaders, and leading investment partnersShared on the Same Stage, Closely Aligned with“Make the Deal Happen”Core: Deconstructing the logic behind discovering, pricing, and trading healthcare innovation assets, empowering companies to connect with buyers and helping capital identify high-quality assets, thereby turning dialogue directly into transactions.
*More sub-forums will be updated soon
Today, the full agenda and the first wave of keynote speakers for the conference have been officially unveiled! The investors, industry leaders, and scientists you want to meet, the high-quality projects you wish to connect with, and the cutting-edge topics you want to follow are all here.
Deconstructing Trading Pain Points Layer by Layer: From Macro Trends to Niche Segments
When the Right People Sit Down Together, What Conversations Truly Seal the Deal?
From global trends in the flow of medical assets to the industrialization pathways of innovative enterprises; from the final stretch before an IPO to the next anchor point for capital—the main forum’s four segments progress layer by layer, covering the entire chain of macroeconomic analysis, industry practice, capital operations, and investment trends.
The Hot Topic Forums delve into the most active sub-sectors in current transactions, including brain-computer interfaces, large AI models for healthcare, ophthalmic innovation, business development (BD) for innovative drugs, and the global expansion of pharmaceuticals and medical devices, directly addressing the most thorny real-world challenges in each field:
Who will foot the bill after breakthroughs in brain-computer interface (BCI) technology? How do clinical scenarios and business models intersect? How can large medical AI models be deployed in real-world settings? How can technical barriers, product forms, and market potential be aligned? In the current environment, how should licensing deals for innovative drugs be priced? How can negotiations be structured to avoid losses while not missing out on opportunities? Regarding entry barriers, partner selection, and localization strategies in European and American markets—how can companies expanding overseas break through? ...
The answers to these questions will be revealed one by one at the forum.
Featured Forums
Hot Tracks Sub-forum
From macro insights at the main forum, to in-depth analysis at thematic forums, and precise matchmaking in exhibition and negotiation zones—we are committed to presenting a panoramic view of the year’s new assets, new transactions, and new ecosystems in the industry, enabling“Spot Innovation, Seek Collaboration, Facilitate Transactions”Become the most distinctive hallmark of the conference.
May 19–21, see you in Shanghai. Bring your projects, your needs, and your business cards, and let this conference be the starting point for your next deal.
Conference Name:2026 Future Healthcare & Medicine Top 100 Conference
Conference Theme:Chinese Assets
Conference Time:May 19–21, 2025, 09:00–17:00
Conference Venue:Shanghai Minhang District Platinum Hanjue Hotel
Organization:
Organizer: VCBeat
Co-organizers of the Forum: Probe Capital, Jiuhao Capital, Vision Capital, Qifeng Capital, Mingshi Brain-Computer Interface, Shijing Medical, Hong Kong Biotechnology Organization (HKBIO), Guotai Haitong Policy and Industry Research Institute, Ferryman SCM Club
Forum Supporting Organizations: Pivotal bioVenture, National Innovation Center of the Yangtze River Delta, FreeS Fund, Qisheng Capital, Shangjun Investment, Danlu Capital, Frost & Sullivan, China Out-of-Hospital Marketing Alliance, China Academy of Information and Communications Technology (CAICT), CEIBS Alumni Healthcare Industry Association
Chief Supporting Organization: CEIBS Alumni Healthcare Industry Association
Supporting Organizations: Qiming Venture Partners, Shenzhen Capital Group, Legend Capital, CAS Star, Boyuan Capital, Sequoia China, Proxima Investment, Huagai Capital, Yuanhe Origin, Panlin Capital, FreesFund, Chende Capital, GTJA Investment, Bencao Capital, Xianfeng Qiyun, Qifeng Capital, Heying Capital, Guosheng Capital
Selection Support Platforms: Transfar Sci-Tech City, International Medical Device City, Dolphin Digital Healthcare Industrial Park, Jiangsu Medical Device Technology Industrial Park, Liangzhu Life Science Town, Wuxi International Life Science Park, Wuxi Precision Medicine Industrial Park, Wuzhong Biopharmaceutical Industrial Park, Wuhan Gaoke Medical Device Park, Xingbei·Free Trade Zone No. 1
Conference Media Partners: Wei Jieyao, Taidu, International Ophthalmology News, Bioon, Sina Medicine, Bai Ao Gu, Exhibition Industry, Big Health Faction, Yao Fangzhou, Yidu Medicine, BCI Brain-Computer Technology
Conference Partners:
Jienno Medical Management Group Co., Ltd., Hunan Medical Device Industrial Park, Guangzhou Shijing Medical Software Co., Ltd., Shanghai Panlin Asset Management Co., Ltd., Beijing Yuewei Medical Technology Co., Ltd., Beijing Jiuhao Consulting Co., Ltd., Beijing Zhishu Medical Devices Co., Ltd., Shanghai Qizhifeng Technology Development Co., Ltd., Mingdong Vision (Beijing) Technology Co., Ltd., Xi'an Beilin Zhuoshuniao Internet Hospital Co., Ltd., Hangzhou Xiran Medical Device Technology Co., Ltd., Beijing Zhiran Medical Technology Co., Ltd., Shanghai Shuli Intelligent Technology Co., Ltd., Huimei Digital Technology (Beijing) Medical Technology Co., Ltd., Hangzhou Xuzhishi Technology Co., Ltd., Yingke Consultants (Beijing) Co., Ltd., Lejian Health Technology Group Co., Ltd., NVIDIA, Hangzhou Shenluo Medical Technology Co., Ltd., Zhejiang Kayi Smart Hospital Technology Co., Ltd., Sichuan Xinyuan Biological Electronic Technology Co., Ltd., Hangzhou Aosaurui Biomedical Technology Co., Ltd., Beijing Qingsong Yikang Information Technology Co., Ltd., Guoyang Ailian Health Technology (Beijing) Co., Ltd., Chengdu Tayu Technology Consulting Co., Ltd.
Scan the QR Code to Register